13-52028094-T-TA
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_021645.6(UTP14C):c.-486-213dupA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00778 in 143,996 control chromosomes in the GnomAD database, including 4 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0078 ( 4 hom., cov: 33)
Consequence
UTP14C
NM_021645.6 intron
NM_021645.6 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.95
Genes affected
UTP14C (HGNC:20321): (UTP14C small subunit processome component) Predicted to be involved in several processes, including meiotic cell cycle; rRNA processing; and spermatogenesis. Located in cytosol and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
ALG11 (HGNC:32456): (ALG11 alpha-1,2-mannosyltransferase) This gene encodes a GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase which is localized to the cytosolic side of the endoplasmic reticulum (ER) and catalyzes the transfer of the fourth and fifth mannose residue from GDP-mannose (GDP-Man) to Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol resulting in the production of Man5GlcNAc2-PP-dolichol. Mutations in this gene are associated with congenital disorder of glycosylation type Ip (CDGIP). This gene overlaps but is distinct from the UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) gene. A pseudogene of the GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase has been identified on chromosome 19. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 13-52028094-T-TA is Benign according to our data. Variant chr13-52028094-T-TA is described in ClinVar as [Likely_benign]. Clinvar id is 1707147.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00778 (1120/143996) while in subpopulation AFR AF= 0.0232 (918/39620). AF 95% confidence interval is 0.0219. There are 4 homozygotes in gnomad4. There are 538 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTP14C | NM_021645.6 | c.-486-213dupA | intron_variant | ENST00000521776.2 | NP_067677.4 | |||
ALG11 | NM_001004127.3 | c.1208-213dupA | intron_variant | ENST00000521508.2 | NP_001004127.2 | |||
ALG11 | NR_036571.3 | n.66-213dupA | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UTP14C | ENST00000521776.2 | c.-486-213dupA | intron_variant | 1 | NM_021645.6 | ENSP00000428619.1 | ||||
ALG11 | ENST00000521508.2 | c.1208-213dupA | intron_variant | 1 | NM_001004127.3 | ENSP00000430236.1 |
Frequencies
GnomAD3 genomes AF: 0.00773 AC: 1113AN: 143940Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
1113
AN:
143940
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00778 AC: 1120AN: 143996Hom.: 4 Cov.: 33 AF XY: 0.00771 AC XY: 538AN XY: 69778
GnomAD4 genome
AF:
AC:
1120
AN:
143996
Hom.:
Cov.:
33
AF XY:
AC XY:
538
AN XY:
69778
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 03, 2020 | See Variant Classification Assertion Criteria. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at